Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
In a previous study, we identified somatic mutations of SF3B1, a gene encoding a core component of RNA splicing machinery, in patients with myelodysplastic syndrome (MDS). Here, we define the clinical significance of these mutations in MDS and myelodysplastic/myeloproliferative neoplasms (MDS/MPN)....
Main Authors: | Malcovati, L, Papaemmanuil, E, Bowen, D, Boultwood, J, Della Porta, MG, Pascutto, C, Travaglino, E, Groves, M, Godfrey, A, Ambaglio, I, Gallì, A, Vià, D, Conte, S, Tauro, S, Keenan, N, Hyslop, A, Hinton, J, Mudie, L, Wainscoat, J, Futreal, P, Stratton, MR, Campbell, P, Hellström-Lindberg, E, Cazzola, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Myelodysplastic/myeloproliferative disorders
by: Luca Malcovati, et al.
Published: (2008-01-01) -
Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
by: Luca Malcovati, et al.
Published: (2014-11-01) -
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
by: Mario Cazzola
Published: (2011-03-01) -
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool
by: Matteo G. Della Porta, et al.
Published: (2012-04-01) -
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2009)